Ozanimod is a sphingosine-1-phosphate (S1P) receptor modulator used in the treatment of relapsing forms of multiple sclerosis (MS) and ulcerative colitis. It works by retaining lymphocytes in lymph nodes, reducing immune-mediated inflammation. Ozanimod API is manufactured under GMP-compliant conditions and is suitable for oral tablet formulations.

Ozanimod API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.